Results
Differentially Expressed miRNAs List
| miRNA ID | Source ID | Cancer Type | Cancer Subtype | Cell Line | Design | logFC | Expression Status | Experiment ID |
|---|---|---|---|---|---|---|---|---|
| hsa-miR-425 | GSE6188 | esophageal cancer | esophageal cancer | N/A | cancer vs normal | -0.24 | DOWN | EXP00031 |
| hsa-miR-425 | GSE17498 | lymphoma | lymphoma | N/A | cancer vs normal | -1.66 | DOWN | EXP00086 |
| hsa-miR-425 | GSE21036 | prostate cancer | prostate cancer | N/A | cancer vs normal | 0.62 | UP | EXP00101 |
| hsa-miR-425* | GSE21036 | prostate cancer | prostate cancer | N/A | metastasis | 0.78 | UP | EXP00102 |
| hsa-miR-425 | GSE21036 | prostate cancer | prostate cancer | N/A | metastasis | 0.74 | UP | EXP00102 |
| hsa-miR-425 | GSE20099 | esophageal cancer | esophageal cancer | N/A | cancer vs normal | -0.75 | DOWN | EXP00079 |
| hsa-miR-425 | GSE13030 | brain cancer | brain cancer | N/A | cancer vs normal | -0.38 | DOWN | EXP00065 |
| hsa-miR-425 | GSE11016 | kidney cancer | kidney cancer | N/A | cancer vs normal | 0.66 | UP | EXP00054 |
| hsa-miR-425 | GSE11016 | kidney cancer | kidney cancer | N/A | cancer vs normal | 1.22 | UP | EXP00056 |
| hsa-miR-425 | GSE11016 | kidney cancer | kidney cancer | N/A | cancer vs normal | 1.22 | UP | EXP00058 |
| hsa-miR-425 | GSE16025 | lung cancer | lung cancer | N/A | cancer vs normal | 0.20 | UP | EXP00071 |
| hsa-miR-425 | GSE16025 | lung cancer | lung cancer | N/A | cancer vs normal | 0.24 | UP | EXP00072 |
| hsa-miR-425* | GSE21036 | prostate cancer | prostate cancer | N/A | high grade vs low grade | 0.76 | UP | EXP00104 |
| hsa-miR-425* | GSE18546 | sarcoma | sarcoma | N/A | cancer vs normal | 1.44 | UP | EXP00111 |
| hsa-miR-425 | GSE21362 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | 0.73 | UP | EXP00117 |